Tanaka, Atsushi
Shimabukuro, Michio
Okada, Yosuke
Taguchi, Isao
Yamaoka-Tojo, Minako
Tomiyama, Hirofumi
Teragawa, Hiroki
Sugiyama, Seigo
Yoshida, Hisako
Sato, Yasunori
Kawaguchi, Atsushi
Ikehara, Yumi
Machii, Noritaka
Maruhashi, Tatsuya
Shima, Kosuke R.
Takamura, Toshinari
Matsuzawa, Yasushi
Kimura, Kazuo
Sakuma, Masashi
Oyama, Jun-ichi
Inoue, Teruo
Higashi, Yukihito
Ueda, Shinichiro
Node, Koichi
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
https://doi.org/10.1186/s12933-017-0532-8
Funding for this research was provided by:
Nippon Boehringer Ingelheim
Eli Lilly and Company
Article History
Received: 28 February 2017
Accepted: 4 April 2017
First Online: 12 April 2017